SEC Form 4 · accession 0001055726-19-000018

INOVIO PHARMACEUTICALS, INC. · INO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Laurent Humeau

Officer — Chief Scientific Officer

Period of report

Mar 8, 2019

Accepted (ET)

Mar 12, 2019 · 7:20 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001055726

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock^F1	Mar 9, 2019	M	2,666	—	A	24,867	D
Common Stock	Mar 9, 2019	F	898	$3.34	D	23,969	D
Common Stock^F3	Mar 10, 2019	M	2,812	—	A	26,781	D
Common Stock	Mar 10, 2019	F	948	$3.34	D	25,833	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Restricted Stock Unit^F1	—	Mar 9, 2019	M	2,666	D	—	Mar 8, 2029	Common Stock	2,666	0	D
Restricted Stock Unit^F3	—	Mar 10, 2019	M	2,812	D	—	Mar 10, 2027	Common Stock	2,812	2,812	D
Common Stock Option^F5	$3.34	Mar 8, 2019	A	93,200	A	Mar 8, 2019	Mar 8, 2029	Common Stock	93,200	93,200	D
Restricted Stock Unit^F6	—	Mar 8, 2019	A	59,700	A	—	Mar 8, 2029	Common Stock	59,700	59,700	D

Explanation of responses

F1Each restricted stock unit represents a contingent right to receive one share of common stock. The 2,666 restricted stock units vested on March 9, 2019.
F2The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein.
F3Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 5,624 restricted stock units is as follows: 2,812 shares vested on March 10, 2019; 2,812 shares will vest on March 10, 2020. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.
F4The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein.
F5The vesting schedule for the 93,200 options is as follows: 23,300 shares vested on March 8, 2019; 23,300 shares will vest on March 8, 2020; 23,300 shares will vest on March 8, 2021; 23,300 shares will vest on March 8, 2022.
F6Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 59,700 restricted stock units is as follows: 19,900 shares will vest on March 8, 2020; 19,900 shares will vest on March 8, 2021; 19,900 shares will vest on March 10, 2022. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both.